DS-1055a

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS-1055a, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors [Phase 1]

See pricing